Australian study: a drug may have the potential to treat Coronavirus
Canberra, November 4 The University of South Australia issued a communiqué a few days ago, stating that its researchers and their Italian counterparts have discovered that a beta-blocker can help inhibit the spread of lung cancer.
Related papers have been published in “Frontiers in Immunology”, and they call for clinical trials to support the above research.
Nimar Robinson, who is engaged in cancer research at the University of South Australia, introduced that they collaborated with a team in Naples, Italy.
Potential to treat the Coronavirus
and found through animal experiments that the beta-blocker propranolol helps to inhibit the spread of lung cancer, and the inflammation of lung cancer It is similar to the inflammation caused by the new coronavirus.
Robinson introduced that propranolol is usually used to treat heart disease, anxiety and migraine. Recent clinical trials have shown that it is also effective against cancer and other diseases.
The body of patients with new Coronavirus will experience “extreme reactions” such as inflammation, and beta blockers can reduce this “extreme reactions”, reduce inflammation, and help rebalance the immune system.
Researchers believe that the β-adrenergic channel should be studied more deeply to use it as a possible target for reducing inflammation caused by the new coronavirus.
In the next step, they will conduct clinical trials to explore Coronavirus therapy based on their experience in treating cancer.
